secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUCELL CORP /DE/ (ICCC)
CIK:        0000811641
Form:       8-K
Filed at:   2026-03-18T23:59:59+00:00
Accession:  0001437749-26-008842
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmuCell appoints Kathy Turner to board, replacing retiring Steven Rosgen
-------------------------------------------------------------------------

- Steven Rosgen resigns from the board effective April 1, 2026, after 8 years of service.
- Kathy Turner elected to board effective April 1; will chair Compensation Committee and serve on Audit Committee.
- Turner brings 30+ years of animal health experience, including former Elanco board member and IDEXX/Abbott leadership roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811641/000143774926008842/0001437749-26-008842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811641/000143774926008842/iccc20260318_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-008842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer